| Dr Robert J Summerer, DO | |
|
323 Sw 10th St, Madison, SD 57042-3200 | |
| (605) 256-6551 | |
| (605) 256-6469 |
| Full Name | Dr Robert J Summerer |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 40 Years |
| Location | 323 Sw 10th St, Madison, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558544536 | NPI | - | NPPES |
| 7301640 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 4521 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Madison Regional Health System | Madison, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Madison Community Hospital | 3779579743 | 39 |
News Archive
Genzyme, a subsidiary of sanofi-aventis Group, announced today that it will present new data from its completed Phase 2 trial of the investigational drug alemtuzumab for multiple sclerosis at the American Academy of Neurology's 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.
The senior medical director of Hong Kong's Centre for Health Protection, Raymond Ho Lei-ming, on Tuesday warned residents that HIV prevalence in the region is increasing among men who have sex with men, Hong Kong's Standard reports (Chui, The Standard, 9/17).
The Wall Street Journal examines Lifeline Express, "the world's first hospital on rails," which is run by Impact India, a group that "initially focused on immunization and prevention of diseases such as polio and malaria." Its success has spread to China and Zimbabwe, where three Lifeline Express trains are operated, and to "hospital river boats based on the India model have been set up to tend to patients in Bangladesh and Cambodia." It has also been used as a model for other health projects in India, according to the newspaper.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.
› Verified 3 days ago
| Entity Name | Madison Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588644058 PECOS PAC ID: 3779579743 Enrollment ID: O20040423000982 |
News Archive
Genzyme, a subsidiary of sanofi-aventis Group, announced today that it will present new data from its completed Phase 2 trial of the investigational drug alemtuzumab for multiple sclerosis at the American Academy of Neurology's 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.
The senior medical director of Hong Kong's Centre for Health Protection, Raymond Ho Lei-ming, on Tuesday warned residents that HIV prevalence in the region is increasing among men who have sex with men, Hong Kong's Standard reports (Chui, The Standard, 9/17).
The Wall Street Journal examines Lifeline Express, "the world's first hospital on rails," which is run by Impact India, a group that "initially focused on immunization and prevention of diseases such as polio and malaria." Its success has spread to China and Zimbabwe, where three Lifeline Express trains are operated, and to "hospital river boats based on the India model have been set up to tend to patients in Bangladesh and Cambodia." It has also been used as a model for other health projects in India, according to the newspaper.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert J Summerer, DO 323 Sw 10th St, Madison, SD 57042-3200 Ph: (605) 256-6551 | Dr Robert J Summerer, DO 323 Sw 10th St, Madison, SD 57042-3200 Ph: (605) 256-6551 |
News Archive
Genzyme, a subsidiary of sanofi-aventis Group, announced today that it will present new data from its completed Phase 2 trial of the investigational drug alemtuzumab for multiple sclerosis at the American Academy of Neurology's 63rd Annual Meeting in Hawaii, April 9 - 16, 2011.
The senior medical director of Hong Kong's Centre for Health Protection, Raymond Ho Lei-ming, on Tuesday warned residents that HIV prevalence in the region is increasing among men who have sex with men, Hong Kong's Standard reports (Chui, The Standard, 9/17).
The Wall Street Journal examines Lifeline Express, "the world's first hospital on rails," which is run by Impact India, a group that "initially focused on immunization and prevention of diseases such as polio and malaria." Its success has spread to China and Zimbabwe, where three Lifeline Express trains are operated, and to "hospital river boats based on the India model have been set up to tend to patients in Bangladesh and Cambodia." It has also been used as a model for other health projects in India, according to the newspaper.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced a collaborative study with Almac's Diagnostics division for the Company's doxorubicin luteinizing hormone-releasing hormone (LHRH) targeted conjugate compound, AEZS-108, aimed at determining LHRH receptor expression through the development of a companion diagnostic tool.
› Verified 3 days ago